Cypress Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3,122
Closed -$298K – 108
2025
Q4
$298K Hold
3,122
– – 0.07% 96
2025
Q3
$305K Sell
3,122
-28
-0.9% -$2.9K 0.07% 96
2025
Q2
$338K Hold
3,150
– – 0.08% 95
2025
Q1
$318K Hold
3,150
– – 0.09% 97
2024
Q4
$281K Buy
3,150
+150
+5% +$13.2K 0.07% 99
2024
Q3
$251K Hold
3,000
– – 0.06% 100
2024
Q2
$231K Hold
3,000
– – 0.06% 98
2024
Q1
$205K Buy
+3,000
New +$193K 0.06% 110

Other funds holding BSX

Cypress Asset Management's BSX Position: Q1 2026 in Review

Cypress Asset Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,122 shares — an estimated $298K sold.

Cypress Asset Management first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $338K in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cypress Asset Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Cypress Asset Management sold 3,122 Boston Scientific shares in Q1 2026, an estimated $298K.
  • Cypress Asset Management first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
  • Cypress Asset Management's Boston Scientific position peaked at $338K in Q2 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cypress Asset Management's 13F filing for Q1 2026, filed 7 Aug 2026.